Literature DB >> 3950236

Effects of staged versus sudden reperfusion after acute coronary occlusion in the dog.

S Yamazaki, Y Fujibayashi, R E Rajagopalan, S Meerbaum, E Corday.   

Abstract

Sudden and staged reperfusion after experimental coronary artery occlusion was studied in relation to recovery of cardiac function and postreperfusion arrhythmias. Eighteen closed chest dogs with 3 hour intracoronary balloon occlusion of the proximal left anterior descending coronary artery were studied using two-dimensional echocardiography over a period of 3 weeks after reperfusion. Nine dogs had sudden reperfusion by abrupt balloon deflation. In nine other dogs reperfusion was staged with partial reflow (20 ml/min) for 2 hours through the central lumen of the catheter during persisting intracoronary balloon inflation, followed by balloon deflation and full reperfusion. Within the first 30 minutes of sudden reperfusion, ischemic zone end-diastolic wall thickness increased significantly, from 6.8 +/- 0.3 mm at 3 hours of occlusion to 10.2 +/- 2.6 mm (p less than 0.05). In contrast, at 30 minutes of partial reflow, wall thickness was 7.5 +/- 0.7 versus 6.8 +/- 0.7 mm at 3 hours of occlusion (NS). A small temporary increase in end-diastolic wall thickness was noted when full reflow was established after 2 hours of staged reperfusion. However, wall thickness was normal on the first day in the staged reperfusion series, while sudden reperfusion delayed recovery to 7 days. Function of the ischemic zone failed to improve substantially until day 3 after sudden reperfusion, whereas it improved consistently starting as early as 30 minutes after institution of the staged reperfusion.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1986        PMID: 3950236     DOI: 10.1016/s0735-1097(86)80466-1

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  10 in total

1.  Myocardial protection during surgical intervention for treatment of acute myocardial infarction.

Authors:  F Beyersdorf; G D Buckberg
Journal:  Tex Heart Inst J       Date:  1992

2.  The failure of radical scavengers to attenuate the incidence of reperfusion arrhythmias despite improvement of cardiac function.

Authors:  K K Minezaki; H Nakazawa; Y Shinozaki; K Ichimori; H Okino
Journal:  Heart Vessels       Date:  1992       Impact factor: 2.037

3.  The detection of technical failures in perfused heart with ischemia and reperfusion by epicardial NADH fluorescence.

Authors:  K K Minezaki; Y Shinozaki; H Nakazawa; Y Yamada; H Okino
Journal:  Heart Vessels       Date:  1990       Impact factor: 2.037

4.  Reperfusion injury after acute myocardial infarction.

Authors:  E D Grech; M J Jackson; D R Ramsdale
Journal:  BMJ       Date:  1995-02-25

Review 5.  Controlling Reperfusion Injury With Controlled Reperfusion: Historical Perspectives and New Paradigms.

Authors:  Demetria M Fischesser; Bin Bo; Rachel P Benton; Haili Su; Newsha Jahanpanah; Kevin J Haworth
Journal:  J Cardiovasc Pharmacol Ther       Date:  2021-09-17       Impact factor: 2.457

6.  Low-dose bisphenol A and estrogen increase ventricular arrhythmias following ischemia-reperfusion in female rat hearts.

Authors:  Sujuan Yan; Weizhong Song; Yamei Chen; Kui Hong; Jack Rubinstein; Hong-Sheng Wang
Journal:  Food Chem Toxicol       Date:  2013-02-18       Impact factor: 6.023

7.  Experiences in intravenous urokinase treatment of 100 acute myocardial infarction patients.

Authors:  H Y Zhao; H B Li; L Wang; X H Zheng; H Wu
Journal:  J Tongji Med Univ       Date:  1991

8.  Coronary artery stenosis controlled by distal perfusion pressure: description of the servo-system and time-dependent changes in regional myocardial blood flow.

Authors:  F W Prinzen; R Alewijnse; G J van der Vusse; R T Kruger; T van de Nagel; R S Reneman
Journal:  Basic Res Cardiol       Date:  1987 Jul-Aug       Impact factor: 17.165

Review 9.  Cardiac metabolism as a driver and therapeutic target of myocardial infarction.

Authors:  Coert J Zuurbier; Luc Bertrand; Christoph R Beauloye; Ioanna Andreadou; Marisol Ruiz-Meana; Nichlas R Jespersen; Duvaraka Kula-Alwar; Hiran A Prag; Hans Eric Botker; Maija Dambrova; Christophe Montessuit; Tuuli Kaambre; Edgars Liepinsh; Paul S Brookes; Thomas Krieg
Journal:  J Cell Mol Med       Date:  2020-05-08       Impact factor: 5.310

10.  H2S Pretreatment Is Promigratory and Decreases Ischemia/Reperfusion Injury in Human Microvascular Endothelial Cells.

Authors:  Elisa Zicola; Elisa Arrigo; Daniele Mancardi
Journal:  Oxid Med Cell Longev       Date:  2021-04-15       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.